Journal Pre-proofs Novel Cilengitide-based Cyclic RGD Peptides as αvβ 3 Integrin Inhibitors Chhuttan L. Meena, Dharmendra Singh, Michael Weinmüller, Florian Reichart, Abha Dangi, Udaya Kiran Marelli, Stefan Zahler, Gangadhar J. Sanjayan PII: S0960-894X(20)30111-6 DOI: https://doi.org/10.1016/j.bmcl.2020.127039 Reference: BMCL 127039 To appear in: Bioorganic & Medicinal Chemistry Letters Received Date: 22 November 2019 Revised Date: 11 February 2020 Accepted Date: 14 February 2020 Please cite this article as: Meena, C.L., Singh, D., Weinmüller, M., Reichart, F., Dangi, A., Kiran Marelli, U., Zahler, S., Sanjayan, G.J., Novel Cilengitide-based Cyclic RGD Peptides as αvβ 3 Integrin Inhibitors, Bioorganic & Medicinal Chemistry Letters (2020), doi: https://doi.org/10.1016/j.bmcl.2020.127039 This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Ltd.